Immune tolerance induction in hemophilia patients with inhibitors: costly can be cheaper

Twenty‐five years' experience of prophylactic treatment in severe haemophilia A and B

1992 • 958 citations

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

1994 • 352 citations

The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII

1981 • 303 citations

Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX Inhibitors

1997 • 287 citations

Blood — Principles and Practice of Hematology

1995 • 278 citations

Clinical experience with recombinant factor VIIa

1998 • 224 citations

Mortality and causes of death in Dutch haemophiliacs, 1973–86

1989 • 209 citations

Incidence of inhibitors in haemophilia A patients – a review of recent studies of recombinant and plasma‐derived factor VIII concentrates

1999 • 208 citations

The Use of Porcine Factor VIII Concentrate (Hyate:C) in the Treatment of Patients With Inhibitor Antibodies to Factor VIII

1989 • 151 citations

Tolerance induction using the Malmö treatment model 1982–1995

1999 • 141 citations

Immune Tolerance in Hemophilia-Principal Results from the International Registry

1994 • 140 citations

Induction of Immune Tolerance to Factor VIII in Hemophiliacs With Inhibitors

1988 • 126 citations

Mortality before and after HIV infection in the complete UK population of haemophiliacs

1995 • 126 citations

A Multicenter Study of Recombinant Factor VIII (RecombinateTM) in Previously Treated Patients with Hemophilia A

1997 • 119 citations

Prophylactic Use of Factor VIII: an Economic Evaluation

1998 • 100 citations

Cause of death in hemophilia a patients in the United States from 1968 to 1979

1988 • 81 citations

Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcome

1990 • 66 citations

Immune tolerance: a synopsis of the international experience

1998 • 64 citations

International Immune Tolerance Registry, 1997 Update

1999 • 59 citations

A Multicenter Pharmacosurveillance Study for the Evaluation of the Efficacy and Safety of Recombinant Factor VIII in the Treatment of Patients with Hemophilia A

1997 • 47 citations

Hemophilia Home Treatment:Economic Analysis and Implications for Health Policy

1995 • 34 citations

Immune Tolerance for the Treatment of Factor VIII Inhibitors - Twenty Years' 'Bonn Protocol'

1996 • 22 citations

The Management of Hemophilia Patients With Inhibitors☆

1992 • 16 citations

Musculoskeletal Problems in Hemophilia

2011 • 7 citations

Low-Dose Immune Tolerance Therapy

1996 • 5 citations

Inhibitors to Coagulation: Can We Afford Immune Tolerance Induction Regimens?

1996 • 4 citations

Recombinant factor VIII in hemophilia A: the Canadian experience.

1997 • 3 citations

Immune Tolerance and the Immune Modulation Protocol

1996 • 3 citations

The International Registry of Immune Tolerance: 1994 Update

1996 • 3 citations

The Economics of Immune Tolerance and Treatment of Hemophiliacs with Inhibitors

1996 • 3 citations

Immune Tolerance in Two High Responder, Severe Hemophilia A Patients with Inhibitors: The Importance of High Doses and the Duration of the Treatment

1996 • 2 citations